53
Views
3
CrossRef citations to date
0
Altmetric
Review

Thrombolytic therapy for acute ischemic stroke: 3 h and beyond

, &
Pages 223-233 | Published online: 10 Jan 2014

References

  • Hacke W, Del Zoppo GJ, Harker LA. Thrombosis and cerebrovascular disease. In: Recent Advances in Diagnosis and Management of Stroke. Poeck K, Ringelstein EB, Tacke W (Eds). Springer-Verlag, NY, USA, 59–64 (1987).
  • Fieschi C, Argentino C, Lenzi GL et al. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J. Neurol. Sci. 91, 311–321 (1989).
  • Collins RC, Dobkin BH, Choi DW. Selective vulnerability of the brain: new insights of the brain: new insights into the pathophysio logy of stroke. Ann. Intern. Med. 110, 992–1000 (1989).
  • Shivaishi K, Sharp FR, Simon RP. Sequential metabolic changes in rat brain following middle cerebral artery occlusion: a 2-deoxyglucose study. J. Cereb. Blood Flow Metab. 9, 765–773 (1989).
  • Sussman BJ, Fitch TSP. Thrombolysis with fibrinolysin in cerebral arterial occlusion JAMA 167, 1705–1709 (1958).
  • The National Institute of Neurological Disorders and stroke rt-PA stroke study group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333, 1581–1587 (1995).
  • Clarke RL, Clifton E. The treatment of cerebro vascular thromboses and embolism with fibrinolytic agents. Am. J. Cardiology 6, 546–551 (1960).
  • Herndon RM, Meyer JS, Johnson JF. Fibrinolysin therapy in thrombotic diseases of the nervous system. J. Mich. Med. Soc. 59, 1684–1692 (1960).
  • Meyer JS, Gilroy J, Barnhart MI, Johnson JF. Anticoagulants plus streptokinase therapy in progressive stroke. JAMA 189, 373 (1964).
  • Meyer JS, Gilroy J, Barnhart MI, Johnson JF. Therapeutic thrombolysis in cerebral thromboembolism. Neurology 13, 927–937 (1963).
  • Fletcher AP, AIK Jersig N, Lewis M et al. A pilot study of urokinase therapy in cerebral infarction. Stroke 7, 135–142 (1976).
  • Doman GA, Dan’s SM, Chambers BR et al. Trials of streptokinase in severe acute ischemic stroke. Lancet 345, 578–579 (1995).
  • The Multicenter Acute Stroke Trial – Europe Study Group: thrombolytic ischemic stroke. N. Engl. J. Med. 335, 145–150 (1996).
  • Multicenter Acute Stroke Trial – Italy (MAST-I) Group. Randomized controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischemic stroke. Lancet 346, 1509–1514 (1995).
  • Donnan GA, Dans SM, Schambers BR et al for the Australian streptokinase (ASK) Trial study Group. Streptokinase for acute ischemic stroke with relationship to time of administration. JAMA 276, 961–966 (1996).
  • Hommel M, Boissel JP, Comu C et al for the MAST study Group. Termination of trial of strepto kinase in severe acute ischemic stroke. Lancet 315, 57 (1994).
  • Hacke W, Kaste M, Fieshi C et al. Intrarenous thrombolysis with recmbinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute stroke study (ECASS). JAMA 274, 1017–1025 (1995).
  • Hacke W, Kaste M, Eieschi C et al. Randomized double blind placebo-controlled trial of thrombolytic therapy with intravenous atteplase in acute ischemic stroke (ECASS II). Second European–Australasion-Acute stroke study Investigators. Lancet 352, 1245 –1251 (1998).
  • Clark WM, Wissman S, Albers GW et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study: a randomized controlled trial. Afteplase thrembolysis for Acute Nonintervention Therapy in Ischemic stroke. JAMA 282, 2019–2026 (1999).
  • Albers GW, Clark WM, Madden KP et al. ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic stroke. Stroke 33, 493–496 (2002).
  • Marler JR, Tilley BC, Lu M et al. Early stroke treatment associated with better outcome: NINOS rtPA stroke study. Neurology 55, 1649–1655 (2000).
  • Albers GW, Bates VE, clark WM et al. Intravenous tissue- type plasminogen activator for treatment of acute stroke: the standard treatment with alteplase to reverse stroke (STARS) study. JAMA 283, 1145–1150 (2000).
  • Hill MD, Buchan AM. Methodology for the Canadian Activase for stroke effectiveness study (CASES). CASES Investigators. Can. J. Neurol. Sci. 8, 232–238 (2001).
  • Ground M, Stenzel C, Schmulling S et al. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 29, 1544–1549 (1998).
  • Chiu DKD, Villar-Cordova C. Intravenous tissue plasminogen activator for acute ischemic stroke. Stroke 29, 18–22 (1998).
  • Trouillar P, Nighoghossian N, Derex L et al. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territony stroke: determination of etiological, topographic and radiological outcome factors. Stroke 29, 2529–2540 (1998).
  • Tanne D, Bates VE, Verro P et al. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke; a multicenter survey. The rtPA-Stroke Survey Group. Neurology 53, 424–427 (1999).
  • Akins PT, Delemos C, Wentworth D et al. Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke? Neurology 55, 1801–1805 (2000).
  • Katzan I, Furlan AF, Lioyd LE et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 283, 1151–1158 (2000).
  • Wang DZ, Rose JA, Honings DS. Treating acute stroke patients with intravenous rtPA: the OSF stroke network experience. Stroke 31, 77–81 (2000).
  • Lopez–Yunez A, Bruno A, Williams L et al. Protocol violations in community-based rtPA stroke treatment are associated with symptomatic intracerebral hemontage. Stroke 32, 12–16 (2001).
  • Bravata DM, Kim N, Concata J et al. Thrombolysis for acute stroke in routine clinical practise. Arch. Intern. Med. 162, 1994–2001 (2002).
  • Merino JG, Silver B, Wong E et al. Extending tissue plasminogen activator use to community and rural stroke patients. Stroke 33, 141–146 (2002).
  • Tanne D, Kasner SE, Demchuk AM et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 105, 1679–1685 (2002).
  • Hacke W, Bluhinki E, Steiner T et al. Dichotomized efficacy end points ECASS intention to treat data set: analysis of ECASS I. Stroke 29, 2073–2075 (1998).
  • Fiorelli M, Bastiasello S, von Kummer R et al. Hemorhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical determination and 3 months outcome in the European Cooperative Acute Stroke Study I (ECASI) cohort. Stroke 30, 2280–2284 (1999).
  • Larnue V, Von Kummer R, Del Zoppo G, Blutimki E. Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in the European Cooperative Acute stroke study. Stroke 28, 957–960 (1997).
  • Del Zoppo GJ, Higastida RT, Furlan AJ et al. PROACT: a phase II randomized trial of recobinant pro-urokinase by direct delivery in acute middle cerebral artery stroke. Stroke 29, 4–11 (1999).
  • Furlan A, Higastida R, Wechsler L et al. Intra arterial prourokinase for acute ischemic stroke: the PROACT II study; a randomized controlled trail. Prolyse in acute cerebral thromboembolism. JAMA 282, 2003–2011 (1998).
  • Berridge DC, Makin GS, Hopkinson BR. Local low dose intra-arterial thrombolytic therapy: the risk of stroke or major haemorrhage. Br. J. Surg. 76, 1230–1233 (1989).
  • Casto L, Caverni L, Canerlingo M et al. Intra-arterial thrombolysis in acute ischemic stroke: experience with a superselective catheter embedded in the eltot. J. Neurol. Neurosug. Psychiatry 60, 667–670 (1996).
  • Wijdicks EF, Nichols DA, Thielen KR et al. Intra-arterial thrombolysis in acute basilar artery thromboembolism: the initial Mayo clinic experience. Mayo Clin. Proc. 72, 1005–1013 (1999).
  • Cronner F, Renonda L, Mattle H et al. Local intra-arterial cerebral thrombolysis in acute ischemic stroke. Stroke 29, 1894–1900 (1998).
  • Edwards MT, Murphy MM, Geraghty JJ et al. Intra-arterial cerebral thrombolysis for acute ischemic stroke in a community hospital. AJNR Am. J. Neuroradiol. 20, 1682–1687 (1999).
  • Katzan IL, Masaryk TJ, Furhan AJ et al. Intra-arterial thrombolysis for perioperative stroke after open heart surgery. Neurology 52, 1081–1084 (1997).
  • Suarez JI, Sunshine JL, Tarr R et al. Predictors of clinical improvement, angiographic recanalization, and intra cranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 30, 2094–2100 (1999).
  • Schellinger PD, Fiebach JB, Mohr A et al. Thrombolytic therapy for ischemic stroke: a review; part II: intra-arterial thrombolysis, vertbrobasilar stroke, phase IV trials and stroke imaging. Crit. Care Med. 29, 1819–1825 (2001).
  • Slinka U, Mull M, Stelzer A et al. Long-term follow-up of patients after intra-arterial thrombolytic therapy of acute vertebrobasilar artery occlusion. Cerebrovasc. Dis. 12, 214–219 (2001).
  • Aronold M, Nedeltchev K, Sturzenegger M et al. Thrombolysis in patients with acute stroke caused by cervical artery dissection: analysis of 9 patients and review of the literature. Arch. Neurol. 59, 549–553 (2002).
  • Branelt T. Diagnosis and thrombolytic therapy of acute basilar artery occlusion: a review. Clin. Exp. Hypertens. 24, 611–622 (2002).
  • Kidwell CS, Saver JL, Carneado J et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 33, 717–724 (2002).
  • Furlar AJ. Natural history of atherothromboembolic occlusion of cerebral arteries: carotid versus vertebrobasilar territories. In: Thrombolytic Therapy in Acute Ischemic Stroke. Hacke W, del Zoppo GJ, Hirschberg M (Eds). Spinger–Verlag, NY, USA, 71–76 (1991).
  • Hacke W, Zeumer H, Ferbet A et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebro basilar occlusive disease. Stroke 19, 1216–1222 (1998).
  • Schumacher M, Siekmann R, Radu W, Wakhloo AK. Local intra-arterial fibrinolytic therapy in vertebrobasilar occlusion. In: Advances in Neurosurgery. Bauer BL, Brock M, Klinger M (Eds). 22, 30–34 (1994).
  • Brandt T, Von Kummer R, Muller Kuppers M et al. Thrombolytic therapy of acute basilar artery occlusion, variables affecting recanalization and outcome. Stroke 27, 875–881 (1996).
  • Huemer M, Niederwieser V, Ladurner G. Thrombolytic treatment for acute occlusion of the basilar artery. J. Neurol. NeuroSurg. Psychiatry 58, 227–228 (1995).
  • Becker KJ, Monsein LH, Ulatowski J et al. Intra-arterial thrombolysis in vertebrobasilar occlusion. AJNR 17, 255–262 (1996).
  • Cross DT, Moran CIJ, Akins P et al. Relationship between clot location and outcome after basilar artery thrombolysis. AJNR 18, 1221–1228 (1997).
  • Hacke W, Brott T, Caplan L et al. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology 53, S3–S14 (1999).
  • Wardlaw J, del Zoppo G, Yamaguchi T. Thrombolysis for acute ischemic stroke (Cocharane review). Cochrane Database Syst. Rev. 2, CD 000213 (2000).
  • Ringleb PA, Schellinger PD, Schranz C, Hacke W. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke. Useful or harmful? Stroke 33, 1437–1449 (2002).
  • Fisher M. Characterizing the target of acute stroke treatment. Stroke 28, 866–872 (1999).
  • Beaulieu C, Moseley ME. Diffusion-weighted and perfusion-weighted magnetic resonance imaging in clinical stroke. In: Current Review of Cerebrovascular Disease. Fourth Edition. Fisher M, Bogousslavsky J (Eds). Current Medicine, PA, USA, 59–68 (2001).
  • Schlaug G, Benfield A, Baird AE et al. The ischemic penumbra: operationally defined by diffusion perfusion MRI. Neurology 53, 1528–1537 (1999).
  • Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 34, 2729–2735 (2003).
  • Kidwell CS, Saver JL, Mattiello J et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann. Neurol. 47, 462–469 (2000).
  • Li F, Liu KF. Secondary decline in apparent diffusion coefficient and neurological outcome after a short period of focal brain ischemia in rats. Ann. Neurol. 48, 236–244 (2000).
  • Parsons MW, Barber PA, Chalk J et al. Diffusion and perfusion-weighted MRI response to thrombolysis in stroke. Ann. Neurol. 51, 28–37 (2002).
  • Neumann-Haeflin T, de Rochemont M, Fiebach JB et al. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle artery occlusion. Stroke 35, 109–115 (2004).
  • Fisher M, Davalos A. Emerging therapies for cerebrovascular disorders. Stroke 35, 367–369 (2004).
  • Eastwood JD, Lev MH, Provenzale JM. Perfusion CT with iodinatd contrast material. AJR 180, 3–12 (2003).
  • Wintermark M, Reichhart M, Thiran JP et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann. Neurol. 51, 417–432 (2000).
  • Grotta JC. Combination therapy stroke trial: rtPA +/- lubeluzole. Stroke 31, 278 (2002).
  • Lyden PD, Astiwood T. The Clomethole Acute Stroke study in Ischemic, Hemorrhage, and tPA treated stroke: design of a phase III trial in the United States and Canada. J. Stroke Cerebrovasc. Dis. 6, 435–441 (1998).
  • Albers GW, Amarenco P, Easton JD, Sacco Rl, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126, S483–S512 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.